Triple-negative breast cancer: new hope for an existing drug
RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...
Prescribing personalized lifestyle interventions to improve prostate cancer treatments
David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres...
$2 million dollars awarded to RI-MUHC team studying lung health
Dr. Benjamin Smith receives CIHR funding to lead research on inflammation and lung health in diverse populations
A modernized Clinical Trials Network to tackle health challenges associated with HIV and other sexually transmitted and blood-borne infections in Canada
Dr. Marina Klein will lead the network...